Physician profile
Jocelyn Slaughter
NPI 1134384829
$1,231.65
in general payments reported to CMS, 2019-2025
14 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $213 · 2021: $174 · 2022: $96.01 · 2023: $26.46 · 2024: $71.36 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $309.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $389.26 | 2019-2023 | Wegovy |
| Abbvie INC. | $302.30 | 2019-2022 | |
| Stryker Corporation | $140.95 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $101.04 | 2024-2025 | Veozah |
| Myovant Sciences INC. | $50.22 | 2021-2022 | |
| Zyla Life Sciences, INC. | $49.66 | 2019 | |
| Hologic Sales and Service, LLC | $42.40 | 2021 | |
| Organon LLC | $40.59 | 2025 | Nexplanon |
| Allergan, INC. | $35.74 | 2019 | |
| Exeltis, USA INC. | $17.44 | 2022 | |
| Lupin INC. | $16.71 | 2019 | |
| Daiichi Sankyo INC. | $16.14 | 2019 | |
| Galderma Laboratories, L.P. | $15.88 | 2022 | |
| Boston Scientific Corporation | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jocelyn Slaughter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.